Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d): Difference between revisions

From GxPlex

Jump to: navigation, search
imported>GxPlexBot
Import from GxPlex Excel
gxplex>GxPlexBot
Import from GxPlex Excel
(No difference)

Revision as of 17:29, 15 July 2026



Document information
Reference GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004
Validity area GBR
Scope(s) HM
Document name The Medicines for Human Use (Clinical Trials) Regulations 2004
Version / Revision 01-May-2004
Status Current
Document type Legal act
Language(s) EN
Description The Medicines for Human Use (Clinical Trials) Regulations 2004
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 — Unit 2.3.3
Scope HM
Document part Article 15

(5) (d)

Language EN
Original entry by Florian Adragna
Contributors
Tags Ethics committee, Investigator, Site staff
Comment Ethics committee opinion: considerations and criteria

Content

Ethics committee opinion 15.— [...] (5) In preparing its opinion, the committee shall consider, in particular, the following matters—

(d)the suitability of the investigator and supporting staff;